Cargando…

Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy?

SIMPLE SUMMARY: Progress in pancreatic ductal adenocarcinoma cancer (PDAC) has been, and still is, difficult. Compared to other solid tumors, the PDAC’s tumor microenvironment (TME) is unique and complex and prevents systemic agents from effectively penetrating and killing tumor cells. Radiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benkhaled, Sofian, Peters, Cedric, Jullian, Nicolas, Arsenijevic, Tatjana, Navez, Julie, Van Gestel, Dirk, Moretti, Luigi, Van Laethem, Jean-Luc, Bouchart, Christelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913158/ https://www.ncbi.nlm.nih.gov/pubmed/36765726 http://dx.doi.org/10.3390/cancers15030768

Ejemplares similares

Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?
por: Bouchart, Christelle, et al.
Publicado: (2020)

Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
por: Manderlier, Martin, et al.
Publicado: (2022)

Boost modalities in cervical cancer: dosimetric comparison between intracavitary BT vs. intracavitary + interstitial BT vs. SBRT.
por: Benkhaled, Sofian, et al.
Publicado: (2023)

Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma
por: Bouchart, Christelle, et al.
Publicado: (2021)

The State of the Art of Radiotherapy for Non-melanoma Skin Cancer: A Review of the Literature
por: Benkhaled, Sofian, et al.
Publicado: (2022)

The current understanding of the immune landscape relative to radiotherapy across tumor types
por: Iliadi, Chrysanthi, et al.
Publicado: (2023)

What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?
por: Navez, Julie, et al.
Publicado: (2021)

Pancreatic Cancer Meets Human Microbiota: Close Encounters of the Third Kind
por: Arsenijevic, Tatjana, et al.
Publicado: (2021)

Characteristics and dosimetric impact of intrafraction motion during peripheral lung cancer stereotactic radiotherapy: is a second midpoint cone beam computed tomography of added value?
por: Benkhaled, Sofian, et al.
Publicado: (2022)

Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
por: Bouchart, Christelle, et al.
Publicado: (2023)

Inter-fraction heart displacement during voluntary deep inspiration breath hold radiation therapy without visual feedback measured by daily CBCT
por: Benkhaled, Sofian, et al.
Publicado: (2022)

Prostate stereotactic body radiotherapy with simultaneous integrated boost: which is the best planning method?
por: Tree, Alison, et al.
Publicado: (2013)

Preoperative and postoperative radiotherapy (RT) for non-small cell lung cancer: still an open question
por: Van Houtte, Paul, et al.
Publicado: (2021)

Modern trends in radiotherapy
por: Deeley, Thomas J
Publicado: (1972)

Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2
por: Bouchart, Christelle, et al.
Publicado: (2019)

EUS-guided placement of fiducial markers for stereotactic body radiation therapy in pancreatic cancer: feasibility, security and a new quality score
por: Figueiredo, Mariana, et al.
Publicado: (2021)

Unresectable and chemoresistant conjunctival squamous cell carcinoma on xeroderma pigmentosum treated by salvage radiation therapy: A case report and a review of the literature
por: Maimouna, Mané, et al.
Publicado: (2022)

Radiotherapy in Modern Clinical Practice
por: Todd, I. D. H.
Publicado: (1976)

Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations
por: Colton, Madyson, et al.
Publicado: (2020)

Intraoperative radiotherapy (IORT) as boost in breast cancer
por: Sedlmayer, Felix, et al.
Publicado: (2017)

Modern Radiotherapy for Pediatric Brain Tumors
por: DeNunzio, Nicholas J., et al.
Publicado: (2020)

Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy
por: Hoefkens, Fien, et al.
Publicado: (2016)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

Radiotherapy and the tumor microenvironment: The “macro” picture
por: Walton, Emma Louise
Publicado: (2017)

Aquaporins Involvement in Pancreas Physiology and in Pancreatic Diseases
por: Arsenijevic, Tatjana, et al.
Publicado: (2019)

Intensity Modulated Radiotherapy with Carbon Ion Radiotherapy Boost for Acinic Cell Carcinoma of the Salivary Glands
por: Schmid, Maximilian P., et al.
Publicado: (2021)

Meta‐Analysis on Induction Chemotherapy in Locally Advanced Nasopharyngeal Carcinoma
por: Mané, Maïmouna, et al.
Publicado: (2020)

Radiotherapy and Brachytherapy : Proceedings of the NATO Advanced Study Institute on Physics of Modern Radiotherapy & Brachytherapy
por: Caner, Alessandra, et al.
Publicado: (2009)

Boost in radiotherapy: external beam sunset, brachytherapy sunrise
por: Maciejewski, Boguslaw
Publicado: (2009)

Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas
por: Cortesi, Annalisa, et al.
Publicado: (2017)

Boosting radiotherapy dose calculation accuracy with deep learning
por: Xing, Yixun, et al.
Publicado: (2020)

Does setup on rectal wall improve rectal cancer boost radiotherapy?
por: Kleijnen, Jean-Paul J. E., et al.
Publicado: (2018)

Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma
por: Yeoh, Kheng-Wei, et al.
Publicado: (2011)

Lymphocyte-sparing pelvic radiotherapy for prostate cancer: An in-silico study
por: Baré, Mathilde, et al.
Publicado: (2022)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Whole Pelvic Radiotherapy With Stereotactic Body Radiotherapy Boost vs. Conventionally Fractionated Radiotherapy for Patients With High or Very High-Risk Prostate Cancer
por: Wang, Shih-Chang, et al.
Publicado: (2020)

Immune targets in the tumor microenvironment treated by radiotherapy
por: Ozpiskin, Omer M., et al.
Publicado: (2019)

The Early Result of Whole Pelvic Radiotherapy and Stereotactic Body Radiotherapy Boost for High-Risk Localized Prostate Cancer
por: Lin, Yu-Wei, et al.
Publicado: (2014)

Role of the Radiotherapy Boost on Local Control in Ductal Carcinoma In Situ
por: Riou, Olivier, et al.
Publicado: (2012)

Is there a role for an external beam boost in cervical cancer radiotherapy?(†)
por: Sethi, Rajni A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sv21to95tuijaqjt6c2oh6oc2k